-+ 0.00%
-+ 0.00%
-+ 0.00%

SIONNA THERAPEUTICS- SION-719 AND SION-451 WERE GENERALLY WELL TOLERATED AND ACHIEVED DESIRED PHARMACOKINETIC TARGETS

Reuters·06/04/2025 11:00:07

Please log in to view news